Literature DB >> 8012417

Proteoglycans and glycosaminoglycans in tumor growth and migration: first experience with tumors of bladder and prostate origin.

D H Schamhart1, K H Kurth.   

Abstract

Proteoglycans (PGs), macromolecules that contain bound glycosaminoglycans (GAGs), are an abundant and ubiquitously distributed group of proteins with a large variety of heterogeneous structures. In recent years a whole range of functions, varying from structural/mechanical support to involvement in the regulation of cell proliferation and cell mobility, cell-cell interactions, and angiogenesis and modulation of the extracellular matrix, have been attributed to these compounds. In this communication an overview is presented dealing with the available knowledge of the (regulatory) properties of PGs and GAGs as participants in tumor growth and metastasis. Acquaintance with the biochemical, biophysical, and biological characteristics of PGs and GAGs may provide a rational basis of the therapeutic use of GAGs in the prevention of tumor growth and invasion. The scarcely available information related to the role of PGs and GAGs in uro-oncology and the potential application of GAGs in the treatment of urological tumors are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012417     DOI: 10.1007/bf00182053

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  63 in total

Review 1.  Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces.

Authors:  W A See; R D Williams
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 2.  Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.

Authors:  M S Soloway; A M Jordan; W M Murphy
Journal:  Prog Clin Biol Res       Date:  1989

3.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

5.  The effects of intravesical pretreatment with pentosan polysulfate on the bacillus Calmette-Guérin induced immune reaction of the guinea pig.

Authors:  T M De Reijke; L C De Boer; P A Steerenberg; P C Vos; K H Kurth; D H Schamhart
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

6.  Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction.

Authors:  R J Garden; B C Liu; S M Redwood; R E Weiss; M J Droller
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

7.  The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells.

Authors:  K J Pienta; W B Isaacs; D Vindivich; D S Coffey
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

8.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

Review 9.  Assembly of extracellular matrix.

Authors:  D F Mosher; J Sottile; C Wu; J A McDonald
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

10.  Extrapulmonary colony formation after intravenous injection of tumour cells into heparin-treated animals.

Authors:  B Maat
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

View more
  1 in total

1.  Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.

Authors:  Zhengrong Guan; Barry S Fuller; Tatsuo Yamamoto; Anthony K Cook; Jennifer S Pollock; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.